Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study-Reference-Cited by-同舟云学术

Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study

Published:2023-04-10 Issue:8 Volume:38 Page:1780-1781
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Judge Parminder K¹²,Herrington William G³²^ORCID,Haynes Richard³²^ORCID

Affiliation:

1. Clinical Trials Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health , Richard Doll Building, Old Road Campus, Roosevelt Drive , , Oxford , UK

2. University of Oxford , Richard Doll Building, Old Road Campus, Roosevelt Drive , , Oxford , UK

3. Medical Research Council Population Health Research Unit, Nuffield Department of Population Health , Richard Doll Building, Old Road Campus, Roosevelt Drive , , Oxford , UK

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfad066/50362468/gfad066.pdf

Reference11 articles.

1. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention;Gansevoort;Lancet,2013

2. The natriuretic-peptide family;Wilkins;Lancet,1997

3. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial;Kostis;Am J Hypertens,2004

4. Clinical pharmacokinetics of sacubitril/valsartan (LCZ696): a novel angiotensin receptor-neprilysin inhibitor;Ayalasomayajula;Clin Pharmacokinet,2017

5. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of angiotensin receptor–neprilysin inhibition in heart failure patients with end‐stage kidney disease on maintenance dialysis: A systematic review and meta‐analysis;European Journal of Heart Failure;2024-09-09